Idiopathic pulmonary fibrosis: New insights into pathogenesis

Clinics in Chest Medicine

Volumn 25, Issue 4 SPEC.ISS., 2004, Pages 749-758

  Noble, Paul W ^a   Homer, Robert J ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Veterans Administration   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MATRIX PROTEIN;

ANGIOGENESIS; APOPTOSIS; CELL PROLIFERATION; CLINICAL FEATURE; EPITHELIUM CELL; FIBROBLAST; FIBROSING ALVEOLITIS; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; LUNG ALVEOLUS EPITHELIUM; LUNG BIOPSY; LUNG FIBROSIS; MYOFIBROBLAST; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW;

EID: 9344223323     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2004.04.003     Document Type: Review

References (81)

1. L.C. Watters, T.E. King, and M.I. Schwarz A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis Am Rev Respir Dis 133 1986 97
2. ATS/ERS International Multidisciplinary Consensus Classification of the idiopathic interstitial pneumonias Am Rev Respir Crit Care Med 165 2002 277
3. H.R. Collard, T.E. King Jr, and B.B. Bartelson Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 168 2003 538
4. K.R. Flaherty, J.A. Mumford, and S. Murray Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia Am J Respir Crit Care Med 168 2003 543
5. P.I. Latsi, R.M. du Bois, and A.G. Nicholson Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends Am J Respir Crit Care Med 168 2003 531
6. J.A. Bjoraker, J.H. Ryu, and M.K. Edwin Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 157 1998 199
7. A.L. Katzenstein, and J.L. Myers Nonspecific interstitial pneumonia and the other idiopathic interstitial pneumonias: classification and diagnostic criteria Am J Surg Pathol 24 2000 1
8. K.R. Flaherty, G.B. Toews, and W.D. Travis Clinical significance of histological classification of idiopathic interstitial pneumonia Eur Respir J 19 2002 275
9. D. Bouros, A.U. Wells, and A.G. Nicholson Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome Am J Respir Crit Care Med 165 2002 1581
10. K.R. Flaherty, T.V. Colby, and W.D. Travis Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease Am J Respir Crit Care Med 167 2003 1410
11. A. Pardo, and M. Selman Idiopathic pulmonary fibrosis: new insights in its pathogenesis Int J Biochem Cell Biol 34 2002 1534
12. A. Pardo, and M. Selman Molecular mechanisms of pulmonary fibrosis Front Biosci 7 2002 d1743
13. M. Selman, and A. Pardo The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis Am J Respir Cell Mol Biol 29 2003 S93
14. M. Selman, and A. Pardo Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder Respir Res 3 2002 3
15. M. Selman, V.J. Thannickal, and A. Pardo Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches Drugs 64 2004 405
16. P.W. Noble Idiopathic pulmonary fibrosis: new insights into classification and pathogenesis usher in a new era therapeutic approaches Am J Respir Cell Mol Biol 29 2003 S27
17. V.J. Thannickal, G.B. Toews, and E.S. White Mechanisms of pulmonary fibrosis Annu Rev Med 55 2004 395
18. W.W. Merrill, and H.Y. Reynolds Bronchial lavage in inflammatory lung disease Clin Chest Med 4 1983 71
19. P.C. Carre, R.L. Mortenson, and T.E. King Jr Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis: a potential mechanism for the recruitment and activation of neutrophils in lung fibrosis J Clin Invest 88 1991 1802
20. A.L. Katzenstein Pathogenesis of "fibrosis" in interstitial pneumonia: an electron microscopic study Hum Pathol 16 1985 1015
21. K. Kuwano, N. Hagimoto, and T. Maeyama Mitochondria-mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias Lab Invest 82 2002 1695
22. K. Kuwano, N. Hagimoto, and T. Tanaka Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice J Pathol 190 2000 221
23. K. Kuwano, M. Kawasaki, and T. Maeyama Soluble form of fas and fas ligand in BAL fluid from patients with pulmonary fibrosis and bronchiolitis obliterans organizing pneumonia Chest 118 2000 451
24. K. Kuwano, N. Nakashima, and I. Inoshima Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias Eur Respir J 21 2003 232
25. K. Kuwano, N. Hagimoto, and M. Kawasaki Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis J Clin Invest 104 1999 13
26. K. Kuwano, R. Kunitake, and T. Maeyama Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor Am J Physiol Lung Cell Mol Physiol 280 2001 L316
27. R. Wang, O. Ibarra-Sunga, and L. Verlinski Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor Am J Physiol Lung Cell Mol Physiol 279 2000 L143
28. N. Hagimoto, K. Kuwano, and I. Inoshima TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells J Immunol 168 2002 6470
29. A.M. Cantin, R.C. Hubbard, and R.G. Crystal Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis Am Rev Respir Dis 139 1989 370
30. R.G. Crystal Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention Am J Med 91 1991 39S
31. D. Saleh, P.J. Barnes, and A. Giaid Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 155 1997 1763
32. R. Wang, G. Alam, and A. Zagariya Apoptosis of lung epithelial cells in response to TNF-alpha requires angiotensin II generation de novo J Cell Physiol 185 2000 253
33. L.A. Ortiz, J. Lasky, and R.F. Hamilton Jr Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice Exp Lung Res 24 1998 721
34. Y. Zhang, T.C. Lee, and B. Guillemin Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure J Immunol 150 1993 4188
35. M. Chilosi, V. Poletti, and B. Murer Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63 Lab Invest 82 2002 1335
36. E. Lappi-Blanco, R. Kaarteenaho-Wiik, and S. Salo Laminin-5 gamma2 chain in cryptogenic organizing pneumonia and idiopathic pulmonary fibrosis Am J Respir Crit Care Med 169 2004 27
37. M. Chilosi, V. Poletti, and A. Zamo Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis Am J Pathol 162 2003 1495
38. M.P. Keane, D.A. Arenberg, and J.P. Lynch III The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis J Immunol 159 1997 1437
39. M.P. Keane, T.J. Standiford, and R.M. Strieter Chemokines are important cytokines in the pathogenesis of interstitial lung disease Eur Respir J 10 1997 1199
40. R.M. Strieter, K.M. Starko, and R.I. Enelow Effects of interferon gamma-1b on biomarker expression in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 170 2004 133 140
41. S.N. Giri, D.M. Hyde, and B.J. Marafino Jr Ameliorating effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice Biochem Med Metab Biol 36 1986 194
42. R. Ziesche, E. Hofbauer, and K. Wittmann A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis N Engl J Med 341 1999 1264
43. S. Koyama, E. Sato, and M. Haniuda Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis Am J Respir Crit Care Med 166 2002 382
44. E. Lappi-Blanco, Y. Soini, and V. Kinnula VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia J Pathol 196 2002 220
45. E.A. Renzoni, D.A. Walsh, and M. Salmon Interstitial vascularity in fibrosing alveolitis Am J Respir Crit Care Med 167 2003 438
46. C. Ramos, M. Montano, and J. Garcia-Alvarez Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression Am J Respir Cell Mol Biol 24 2001 591
47. P. Teder, R.W. Vandivier, and D. Jiang Resolution of lung inflammation by CD44 Science 296 2002 155
48. F. Zuo, N. Kaminski, and E. Eugui Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans Proc Natl Acad Sci U S A 99 2002 6292
49. N. Kaminski, J.D. Allard, and J.F. Pittet Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis Proc Natl Acad Sci U S A 97 2000 1778
50. M. Ando, E. Miyazaki, and T. Fukami Interleukin-4-producing cells in idiopathic pulmonary fibrosis: an immunohistochemical study Respirology 4 1999 383
51. C.G. Lee, R.J. Homer, and Z. Zhu Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1) J Exp Med 194 2001 809
52. Y. Martinet, W.N. Rom, and G.R. Grotendorst Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis N Engl J Med 317 1987 202
53. W.N. Rom, P. Basset, and G.A. Fells Alveolar macrophages release an insulin-like growth factor I-type molecule J Clin Invest 82 1988 1685
54. N. Khalil, O. Bereznay, and M. Sporn Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation J Exp Med 170 1989 727
55. N. Khalil, and A.H. Greenberg The role of TGF-beta in pulmonary fibrosis Ciba Found Symp 157 1991 194
56. J.J. Letterio, and A.B. Roberts Transforming growth factor-beta1- deficient mice: identification of isoform-specific activities in vivo J Leukoc Biol 59 1996 769
57. Y.A. Yang, O. Dukhanina, and B. Tang Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects J Clin Invest 109 2002 1607
58. P.J. Sime, Z. Xing, and F.L. Graham Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung J Clin Invest 100 1997 768
59. P.A. Kiely, A. Sant, and R. O'Connor RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death J Biol Chem 277 2002 22581
60. G. Raghu, Y.Y. Chen, and V. Rusch Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs Am Rev Respir Dis 138 1988 703
61. C. Vancheri, M.A. Sortino, and V. Tomaselli Different expression of TNF-alpha receptors and prostaglandin E(2)Production in normal and fibrotic lung fibroblasts: potential implications for the evolution of the inflammatory process Am J Respir Cell Mol Biol 22 2000 628
62. H.W. Zhao, C.J. Lu, and R.J. Yu An increase in hyaluronan by lung fibroblasts: a biomarker for intensity and activity of interstitial pulmonary fibrosis? Respirology 4 1999 131
63. C. Kuhn, and J.A. McDonald The roles of the myofibroblast in idiopathic pulmonary fibrosis: ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis Am J Pathol 138 1991 1257
64. T.E. King Jr, J.A. Tooze, and M.I. Schwarz Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model Am J Respir Crit Care Med 164 2001 1171
65. A.G. Nicholson, T.V. Colby, and R.M. du Bois The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis Am J Respir Crit Care Med 162 2000 2213
66. R.B. Low Modulation of myofibroblast and smooth-muscle phenotypes in the lung Curr Top Pathol 93 1999 19
67. J.J. Tomasek, G. Gabbiani, and B. Hinz Myofibroblasts and mechano-regulation of connective tissue remodelling Nat Rev Mol Cell Biol 3 2002 349
68. B. Hinz, G. Gabbiani, and C. Chaponnier The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo J Cell Biol 157 2002 657
69. K. Zhang, M.D. Rekhter, and D. Gordon Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis: a combined immunohistochemical and in situ hybridization study Am J Pathol 145 1994 114
70. S.H. Phan, K. Zhang, and H.Y. Zhang The myofibroblast as an inflammatory cell in pulmonary fibrosis Curr Top Pathol 93 1999 173
71. H.Y. Zhang, M. Gharaee-Kermani, and K. Zhang Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis Am J Pathol 148 1996 527
72. N. Hashimoto, H. Jin, and T. Liu Bone marrow-derived progenitor cells in pulmonary fibrosis J Clin Invest 113 2004 243
73. H.Y. Zhang, and S.H. Phan Inhibition of myofibroblast apoptosis by transforming growth factor beta(1) Am J Respir Cell Mol Biol 21 1999 658
74. H. Bostrom, K. Willetts, and M. Pekny PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis Cell 85 1996 863
75. G.S. Bogatkevich, E. Tourkina, and R.M. Silver Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway J Biol Chem 276 2001 45184
76. G. Raghu, K.K. Brown, and W.Z. Bradford A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis N Engl J Med 350 2004 125
77. R.M. Strieter, J.A. Belperio, and M.P. Keane Host innate defenses in the lung: the role of cytokines Curr Opin Infect Dis 16 2003 193
78. V. Lama, B.B. Moore, and P. Christensen Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent Am J Respir Cell Mol Biol 27 2002 752
79. J. Wilborn, L.J. Crofford, and M.D. Burdick Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2 J Clin Invest 95 1995 1861
80. Y.W. Tang, J.E. Johnson, and P.J. Browning Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis J Clin Microbiol 41 2003 2633
81. A.A. Liebow, and C.B. Carrington The interstitial pneumonias M. Simon E.J. Potchen M. Le May Frontiers of pulmonary radiology 1969 Grune and Stratton New York 102